QuidelOrtho provides solutions that expand clinical pharmacy services into test-to-treat options that allow for more convenience, accessibility, and added value to the patients and communities you serve.
Company Background
A history of firsts to the promise of the future.
From our earliest beginnings (1939), QuidelOrtho has been committed to the advancement of diagnostic science and improving the lives of people everywhere.
With expertise spanning clinical chemistry, immunoassay, immunohematology, and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, delivering fast, accurate, and reliable results that help improve patient outcomes — from the point of care to lab, clinic to hospital. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.
Product Overview
As the healthcare landscape continues to evolve, the role of pharmacists continues to expand to include much-needed healthcare services. These expanded services help increase access to care, improve patient outcomes, and can reduce overall healthcare costs. Let QuidelOrtho be your test-to-treat partner by providing tools, support, and expertise in these pharmacy programs.
In the point-of-care testing space, QuidelOrtho has two testing lines, SOFIA™ 2 Analyzer and QUICKVUE™ Rapid Lateral-Flow Tests. QuidelOrtho’s unparalleled testing solutions can support testto- treat programs and help you spot trends sooner, respond faster, and chart the course ahead with greater accuracy and confidence.
SOFIA 2 Analyzer
The SOFIA 2 Analyzer has revolutionized the speed and accuracy of diagnostic testing. With 80,000+ placements in pharmacies, urgent care facilities, hospitals, and occupational health among other venues, SOFIA 2 Analyzer is proven to provide reliable results which can result in better outcomes. The system is automated and utilizes fluorescent technology, providing objective results you can rely on to manage patients quickly and properly. The small but sophisticated instrument has multiple integrated data management options available to move data seamlessly based on pharmacy needs. A cost-effective solution with a robust menu allows for platform consolidations while optimizing operational efficiencies. Compact and easy to use with flexible workflows accommodate varying test volumes, improving customer experience.
SOFIA 2 Assays: Influenza A+B, Flu + SARS Antigen FIA, SARS Antigen+ FIA, Strep A+ FIA, RSV FIA and Lyme FIA
QUICKVUE Rapid Lateral-Flow Tests (Rx)
For almost 40 years, QUICKVUE Rapid Lateral Flow Tests have provided a test that is visually read while producing results in minutes, allowing for faster diagnosis and treatment. The QUICKVUE product portfolio has continued to deliver quality results that are well-suited for pharmacy. QUICKVUE Rapid Lateral-Flow Tests encompass areas of infectious diseases and general health.
QUICKVUE Tests: Influenza A+B, Influenza + SARS, SARS Antigen, Strep A, RSV, and Adenoviral Conjunctivitis
QUICKVUE At-Home Tests
Our QUICKVUE COVID-19 Test is a 510(k) cleared test from the U.S. Food and Drug Administration (FDA). This test offers consumers rapid results in the privacy of their own home.
Ordering Information
For ordering information contact pharmacy@quidelortho.com or contact us online at www.quidelortho.com/us/en/healthcareproviders/ pharmacy/contact-us.
